Correction by defects in clotting accelerator activity by administration of methionine and vitamin K and of a new sulfhydryl-substituted methylnaphthoquinone, vitamin K-S(II).
D001777:Blood Coagulation; D006801:Humans; D008715:Methionine / Q000494:pharmacology*; D009285:Naphthoquinones; D014812:Vitamin K / Q000494:pharmacology*
D009285:Naphthoquinones; D014812:Vitamin K; D008715:Methionine
BLOOD COAGULATION; METHIONINE/effects; VITAMIN K/effects